Employers responding to a Business Group on Health survey indicated they are cutting coverage or tightening utilization ...

The US FDA approval marks the second indication for the FcRn inhibitor after its April 2025 approval for generalized ...

Exclusive: Bayer Consumer Health has staked its claim to the GLP-1 companion space, mapping existing brands to user symptoms ...

Amidate (etomidate) and generics are facing a pre-review by an international drug control committee, which could lead to ...

The UK government has pledged up to £2m in funding for nine “cutting-edge” animal-free drug testing projects, with eventual ...

A pioneer of first-in-class oral peptide drugs, Protagonist has opted to let big pharma partners bring its first two products ...

Neurotech company Axoft said it developed a new Fleuron material with the Shroff Lab for research use as it continues to ...

A signature from a New Jersey district court judge has finalized a battle over a settlement agreement that represented over a ...

Experts say lowered demand, staff shortages, and changes to MDR and IVDR are forcing a realignment of the notified body ...

Sophie McGrath, a partner in the life sciences, healthcare and technology groups at global legal firm Goodwin, appraises ...

OMUFA 2020 was just an accomplishment that I will forever treasure. It was a casebook study on how policy making should be ...

The September workshop is an opportunity for the agency to outline the evidence sufficient for marketing approval, as well as ...